semaglutide shortage ending GLP-1 = Over FDA declares semaglutide (Ozempic/Wegovy) shortage
Description
Common signs include: Redness at the injection site Mild swelling or raised bumps Itching or slight tenderness Warmth in the area These reactions are considered relatively common with injectable medications and usually do not mean the treatment needs to be stopped

This stepped approach allows providers to assess tolerability at each stage

Obesity Is a Complex Chronic Disease and Still Highly Stigmatized Obesity is a chronic and complex disease requiring management throughout a persons life, explained Jaime Almandoz of UT Southwestern Medical Center

CDC lists oral oseltamivir, inhaled zanamivir, IV peramivir, or oral baloxavir

Medical weight loss treatment is recommended only after a clinical evaluation to determine safety and appropriateness

Or even better, challenge colonialism and white supremacy with Ilya Parker (they/them)
